Sienna Biopharmaceuticals' Series A Round

Sienna Biopharmaceuticals raised a round of funding on April 28, 2016.

Sienna Biopharmaceuticals (NASDAQ: SNNA) is a medical dermatology and aesthetics company focused on developing safe and effective targeted therapies to treat inflammatory skin conditions and aesthetic…

Articles about Sienna Biopharmaceuticals' Series A Round: